| SC 13D/A | 2013-12-03 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | - | - | EDGAR |
| SC 13D/A | 2013-10-07 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | - | - | EDGAR |
| SC 13D/A | 2013-10-04 | SC Fundamental Value Fund, L.P. | Transcept Pharmaceuticals Inc | 1,123,381 | 6.0% | EDGAR |
| SC 13D/A | 2013-10-03 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | - | - | EDGAR |
| SC 13D/A | 2013-09-19 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | - | - | EDGAR |
| SC 13D | 2013-09-05 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | 2,287,231 | 12.2% | EDGAR |
| SC 13D/A | 2013-08-29 | SC Fundamental Value Fund, L.P. | Transcept Pharmaceuticals Inc | 1,123,381 | 6.0% | EDGAR |
| SC 13D | 2013-08-14 | SC Fundamental Value Fund, L.P. | Transcept Pharmaceuticals Inc | 1,123,381 | 6.0% | EDGAR |
| SC 13G | 2013-08-02 | SC Fundamental Value Fund, L.P. | Transcept Pharmaceuticals Inc | 1,123,381 | 6.0% | EDGAR |
| SC 13G/A | 2013-06-27 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | 2,312,671 | - | EDGAR |
| SC 13G/A | 2013-02-14 | HealthCor Management, L.P. | Transcept Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2013-02-14 | TANG CAPITAL PARTNERS LP | Transcept Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13D/A | 2013-02-07 | New Leaf Ventures I, L.P. | Transcept Pharmaceuticals Inc | 930,931 | 4.9% | EDGAR |
| SC 13G | 2013-02-05 | Roumell Asset Management, LLC | Transcept Pharmaceuticals Inc | 946,790 | - | EDGAR |
| SC 13G/A | 2013-01-29 | SABBY MANAGEMENT, LLC | Transcept Pharmaceuticals Inc | 0 | 0.0% | EDGAR |
| SC 13G | 2012-06-08 | SABBY MANAGEMENT, LLC | Transcept Pharmaceuticals Inc | 1,434,976 | 7.7% | EDGAR |
| SC 13G | 2012-05-04 | TANG CAPITAL PARTNERS LP | Transcept Pharmaceuticals Inc | 1,750,000 | 9.5% | EDGAR |
| SC 13G | 2012-03-30 | HealthCor Management, L.P. | Transcept Pharmaceuticals Inc | 700,000 | 5.0% | EDGAR |
| SC 13D/A | 2011-12-08 | MONTREUX EQUITY PARTNERS II SBIC LP | Transcept Pharmaceuticals Inc | 130,393 | 1.0% | EDGAR |
| SC 13D/A | 2011-11-10 | MONTREUX EQUITY PARTNERS II SBIC LP | Transcept Pharmaceuticals Inc | 353,368 | 2.6% | EDGAR |